The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 03, 2025
Filed:
Apr. 25, 2023
Applicant:
Concert Pharmaceuticals, Inc., Lexington, MA (US);
Inventor:
Roger Tung, Lexington, MA (US);
Assignee:
Concert Pharmaceuticals, Inc., Lexington, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 221/28 (2006.01); A61K 31/195 (2006.01); A61K 31/439 (2006.01); A61K 31/4709 (2006.01); A61K 31/485 (2006.01); A61K 31/49 (2006.01); C07B 59/00 (2006.01); C07D 471/08 (2006.01); C12Q 1/28 (2006.01); G01N 33/49 (2006.01); G01N 33/493 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/28 (2013.01); A61K 31/195 (2013.01); A61K 31/4709 (2013.01); A61K 31/485 (2013.01); A61K 31/49 (2013.01); C07B 59/002 (2013.01); C07D 221/28 (2013.01); C07D 471/08 (2013.01); G01N 33/491 (2013.01); G01N 33/493 (2013.01);
Abstract
This disclosure relates to novel morphinan compounds and their derivatives, pharmaceutically acceptable salts, solvates, and hydrates thereof. This disclosure also provides compositions comprising a compound of this disclosure and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a σreceptor agonist that also has NMDA antagonist activity.